Axsome Therapeutics, Inc. (AXSM): 1 insider purchase in the last two years; 1 trade disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Sep 9, 2025 | Coleman Mark Director | 1,575 | $127.28 | $200.5K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Jul 28, 2022 | Christopher L. Jacobs | purchase | $15,001 - $50,000 |